Abstract:OBJECTIVE:To explore the prognostic factors for the recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) through analyzing the clinical and imaging characteristics of HCC. METHODS:The preoperative data of 230 consecutive HCC cases undergoing LT were retrospectively collected from our hospital from October 2003 to July 2009. There were 210 males and 20 females with a median age of 50 years. Their survival rates were calculated by Kaplan-Meier method. The disease-free survival curves of different prognostic factors were plotted by Kaplan-Meier method. The prognostic factors were analyzed by Log-rank test and Forward Conditional Cox regression respectively to yield the related risk factors and independent risk factors for the recurrence of HCC after LT. RESULTS:The median follow-up period was 29 months (range: 3 - 68). The outcomes included recurrence (n = 77), no recurrence (n = 153) and mortality (n = 63). Their 1-, 3- and 5-year cumulative survival rates and cumulative disease-free survival rates were 84%, 75%, 69% and 73%, 65%, 63% respectively. Univariate analysis with Log-rank test revealed that the following prognostic factors were significant (P < 0.05): age < 50 years, exceeding Milan-criteria, TNM stages of II-III, number of tumor ≥ 2, the diameter of the largest viable tumor > 5 cm, the post-intervention diameter of viable tumor ≥ 30% of entire tumor diameter, tumor distribution > 1 lobe, indistinct boundary of tumor, histological differentiation, serum α-fetoprotein level > 400 ng/ml, the sum of viable tumor diameters ≥ 7.7 cm and intrahepatic portal venous thrombosis. Multivariate analysis with a forward conditional Cox hazard model revealed that the following prognostic factors were independently statistically significant (P < 0.05) : histological differentiation, serum α-fetoprotein level > 400 ng/ml, the sum of viable tumor diameters ≥ 7.7 cm and intrahepatic portal venous thrombosis. CONCLUSIONS:Poor histological differentiation, serum α-fetoprotein level > 400 ng/ml, the sum of viable tumor diameters ≥ 7.7 cm and intrahepatic portal venous thrombosis are significant risk factors. Preoperative aggressive interventional therapy may prolong the disease-free survival period of HCC after LT.

Combined Hounsfield units of hepatocellular carcinoma on computed tomography and PET as a noninvasive predictor of early recurrence after living donor liver transplantation: Time-to-recurrence survival analysis

CT-Based Radiomics for the Recurrence Prediction of Hepatocellular Carcinoma after Surgical Resection

Relationship Between Clinicopathologic Features and Neoplasm Recurrence,prognosis in Hepatocellular Carcinoma after Liver Transplantation

Clonal Origin of Hepatocellular Carcinoma and Recurrence after Liver Transplantation

Investigating the value of pre-treatment 18 F-FDG PET/CT in predicting the pathological characteristic of hepatocellular carcinoma and recurrence after liver transplantation

An FDG PET/CT Metabolic Parameter-Based Nomogram for Predicting the Early Recurrence of Hepatocellular Carcinoma after Liver Transplantation

Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation

Incorporating Tumor Biology to Predict Hepatocellular Carcinoma Recurrence in Patients Undergoing Living Donor Liver Transplantation Using Expanded Selection Criteria

Prediction of tumor recurrence by distinct immunoprofiles in liver transplant patients based on mass cytometry

Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study.

Circulating Cancer Stem Cells Expressing EpCAM/CD90 in Hepatocellular Carcinoma: A Pilot Study for Predicting Tumor Recurrence after Living Donor Liver Transplantation

Prediction of early recurrence of hepatocellular carcinoma after liver transplantation based on computed tomography radiomics nomogram

Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation

Predictive Value of Preoperative 18 Fludeoxyglucose Positron Emission Tomography–Computed Tomography for Survival in Liver Transplantation Due to Hepatocellular Cancer

Association of Phenotypic Transformation of Circulating Tumor Cells and Early Recurrence in Patients with Hepatocellular Carcinoma Following Liver Transplantation

Analysis of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Recurrence Following Liver Transplantation.

Clinical application of PET/CT for liver cancer patients with liver transplantation

Validated preoperative computed tomography risk estimation for postoperative hepatocellular carcinoma recurrence.

[Multivariate Analysis of Recurrence of Hepatocellular Carcinoma after Liver Transplantation].

Scoring Selection Criteria Including Total Tumour Volume And Pretransplant Percentage Of Lymphocytes To Predict Recurrence Of Hepatocellular Carcinoma After Liver Transplantation

Alpha-fetoprotein and 18F-FDG Standard Uptake Value Predict Tumor Recurrence after Liver Transplantation for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Preliminary Experience.